ABSTRACT
The study of the National Institute of Neurological Disorders and Stroke (NINDS) proved that the use of the recombinant tissue plasminogen activator (rtPA) within the first 3 hours since the beginning of the symptomatology of the acute ischemis stroke (AIS) is as well safe as effective...These preliminary data reported in our study show that a strict protocol of thrombolysis IV with rtPA in AIS is feasible to be carried on with good results in a high complexity Center.
Subject(s)
Humans , Aged , Ischemic Attack, Transient/pathology , Ischemic Attack, Transient/therapy , Blood Coagulation Tests , Infusion Pumps , Plasminogen/administration & dosage , Plasminogen/therapeutic use , Thrombolytic Therapy , Tomography, X-Ray Computed , Platelet CountABSTRACT
El número de pacientes que se incluyen en programas de transplante pulmonar es creciente y su sobrevida en lista de espera depende de la posibilidad de acceder a un TxP así como de la progresión de la enfermedad de base. El objetivo de este trabajo es analizar la evolución y sobrevida de los pacientes con enfermedad respiratoria avanzada (ERA) evaluados para trasplante uni y bipulmonar